Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease

Herd, Clare P, Tomlinson, Claire L, Deane, Katherine ORCID: https://orcid.org/0000-0002-0805-2708, Brady, Marian C, Smith, Christina H, Sackley, Catherine M and Clarke, Carl E (2012) Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease. Cochrane Database of Systematic Reviews, 8. CD002812. ISSN 1465-1858

Preview

PDF (Herd-2012-Speech and language) - Published Version Download (411kB) | Preview

Abstract

Parkinson's disease patients commonly suffer from speech and vocal problems including dysarthric speech, reduced loudness and loss of articulation. These symptoms increase in frequency and intensity with progression of the disease). Speech and language therapy (SLT) aims to improve the intelligibility of speech with behavioural treatment techniques or instrumental aids.

Item Type:	Article
Uncontrolled Keywords:	randomized controlled trials as topic,watchful waiting,parkinson disease,speech intelligibility,humans,dysarthria,speech therapy,language therapy,sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School:	Faculty of Medicine and Health Sciences > School of Rehabilitation Sciences
Depositing User:	Pure Connector
Date Deposited:	16 Oct 2013 00:43
Last Modified:	24 Oct 2022 04:47
URI:	https://ueaeprints.uea.ac.uk/id/eprint/43707
DOI:	10.1002/14651858.CD002812.pub2

Actions (login required)

View Item